Health Care Equipment & Services

Discover why the global pharmaceutical logistics market is booming—cold‑chain tech, real‑time tracking, and regulatory compliance drive growth for leaders like Cencora, DHL, UPS, and FedEx.

EssilorLuxottica faces a privacy probe into its smart‑glasses line, while traditional eyewear margins shrink—stock buyers weigh the implications.

Abbott’s Cancerguard seeks FDA clearance to unlock broad adoption, higher reimbursement, and a $150 M revenue boost in the $4.2 billion multi‑cancer market.

Cardinal Health’s FY 2025 10‑K shows disciplined growth, strong specialty‑solutions expansion, and robust governance—insights that help investors gauge future value.

Discover how McKesson’s data‑driven logistics, value‑based pricing, and strong ROE deliver >100% gains, improve patient care, and drive shareholder value in a changing healthcare market.

ResMed’s data‑driven connected devices boost sleep‑disorder care, driving sales, regulatory approval, and supply‑chain resilience while improving patient adherence and cost‑efficiency.

Dexcom’s stock soars after strong earnings, a growing CGM pipeline, and EU expansion plans—showing investors confidence in its diabetes‑care leadership.

Quest Diagnostics reveals that 30% of Lyme‑disease patients also have other tick‑borne antibodies, urging comprehensive multi‑pathogen testing for accurate diagnosis.

Canaccord’s review cuts Stryker’s near‑term target but backs its long‑term value—highlighting supply‑chain hurdles, FDA pressure, but strong diversification, R&D and global reach.

Siemens Healthineers partners with Novo to launch FDA‑cleared ELF blood test, enabling early, non‑invasive fibrosis detection for MASLD/MASH patients—cutting costs, boosting safety, and driving precision diagnostics.